These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33782024)

  • 1. Study protocol of a phase 1 clinical trial establishing the safety of intrapleural administration of liposomal curcumin: curcumin as a palliative treatment for malignant pleural effusion (IPAL-MPE).
    Hocking AJ; Farrall AL; Newhouse S; Sordillo P; Greco K; Karapetis CS; Dougherty B; Klebe S
    BMJ Open; 2021 Mar; 11(3):e047075. PubMed ID: 33782024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial of intrapleural docetaxel administered through an implantable catheter in subjects with a malignant pleural effusion.
    Jones DR; Taylor MD; Petroni GR; Shu J; Burks SG; Daniel TM; Gillenwater HH
    J Thorac Oncol; 2010 Jan; 5(1):75-81. PubMed ID: 19884858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OPTIMUM: a protocol for a multicentre randomised controlled trial comparing Out Patient Talc slurry via Indwelling pleural catheter for Malignant pleural effusion vs Usual inpatient Management.
    Sivakumar P; Douiri A; West A; Rao D; Warwick G; Chen T; Ahmed L
    BMJ Open; 2016 Oct; 6(10):e012795. PubMed ID: 27798020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Safety and Exploration of the Pharmacokinetics of Intrapleural Liposomal Curcumin.
    Hocking A; Tommasi S; Sordillo P; Klebe S
    Int J Nanomedicine; 2020; 15():943-952. PubMed ID: 32103948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol of the Australasian Malignant Pleural Effusion-2 (AMPLE-2) trial: a multicentre randomised study of aggressive versus symptom-guided drainage via indwelling pleural catheters.
    Azzopardi M; Thomas R; Muruganandan S; Lam DC; Garske LA; Kwan BC; Rashid Ali MR; Nguyen PT; Yap E; Horwood FC; Ritchie AJ; Bint M; Tobin CL; Shrestha R; Piccolo F; De Chaneet CC; Creaney J; Newton RU; Hendrie D; Murray K; Read CA; Feller-Kopman D; Maskell NA; Lee YC
    BMJ Open; 2016 Jul; 6(7):e011480. PubMed ID: 27381209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.
    Ren S; Terman DS; Bohach G; Silvers A; Hansen C; Colt H; Sahn SA
    Chest; 2004 Nov; 126(5):1529-39. PubMed ID: 15539723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review.
    Van Meter ME; McKee KY; Kohlwes RJ
    J Gen Intern Med; 2011 Jan; 26(1):70-6. PubMed ID: 20697963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: a phase II study with pharmacokinetic analysis.
    Lombardi G; Nicoletto MO; Gusella M; Fiduccia P; Dalla Palma M; Zuin A; Fiore D; Donach M; Zagonel V
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):781-7. PubMed ID: 22037881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlative analysis from a phase I clinical trial of intrapleural administration of oncolytic vaccinia virus (Olvi-vec) in patients with malignant pleural mesothelioma.
    Chintala NK; Choe JK; McGee E; Bellis R; Saini JK; Banerjee S; Moreira AL; Zauderer MG; Adusumilli PS; Rusch VW
    Front Immunol; 2023; 14():1112960. PubMed ID: 36875061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial.
    Geoerger B; Kang HJ; Yalon-Oren M; Marshall LV; Vezina C; Pappo A; Laetsch TW; Petrilli AS; Ebinger M; Toporski J; Glade-Bender J; Nicholls W; Fox E; DuBois SG; Macy ME; Cohn SL; Pathiraja K; Diede SJ; Ebbinghaus S; Pinto N
    Lancet Oncol; 2020 Jan; 21(1):121-133. PubMed ID: 31812554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study.
    van Zandwijk N; Pavlakis N; Kao SC; Linton A; Boyer MJ; Clarke S; Huynh Y; Chrzanowska A; Fulham MJ; Bailey DL; Cooper WA; Kritharides L; Ridley L; Pattison ST; MacDiarmid J; Brahmbhatt H; Reid G
    Lancet Oncol; 2017 Oct; 18(10):1386-1396. PubMed ID: 28870611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I feasibility and pharmacokinetic study of intrapleural paclitaxel in patients with malignant pleural effusions.
    Perng RP; Wu MF; Lin SY; Chen YM; Lin JY; Whang-Peng J
    Anticancer Drugs; 1997 Jul; 8(6):565-73. PubMed ID: 9300570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
    Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK
    Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I open-label trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study): study protocol.
    Vatandoust S; Bright T; Roy AC; Watson D; Gan S; Bull J; Abbas MN; Karapetis CS
    BMJ Open; 2019 May; 9(5):e026732. PubMed ID: 31061042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer‑mediated malignant pleural effusion.
    Du N; Li X; Li F; Zhao H; Fan Z; Ma J; Fu Y; Kang H
    Oncol Rep; 2013 Jun; 29(6):2332-40. PubMed ID: 23525453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses.
    Sterman DH; Recio A; Carroll RG; Gillespie CT; Haas A; Vachani A; Kapoor V; Sun J; Hodinka R; Brown JL; Corbley MJ; Parr M; Ho M; Pastan I; Machuzak M; Benedict W; Zhang XQ; Lord EM; Litzky LA; Heitjan DF; June CH; Kaiser LR; Vonderheide RH; Albelda SM; Kanther M
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4456-66. PubMed ID: 17671130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.
    Noro R; Kobayashi K; Usuki J; Yomota M; Nishitsuji M; Shimokawa T; Ando M; Hino M; Hagiwara K; Miyanaga A; Seike M; Kubota K; Gemma A;
    Thorac Cancer; 2020 Jul; 11(7):1876-1884. PubMed ID: 32421226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc
    Greil R; Greil-Ressler S; Weiss L; Schönlieb C; Magnes T; Radl B; Bolger GT; Vcelar B; Sordillo PP
    Cancer Chemother Pharmacol; 2018 Oct; 82(4):695-706. PubMed ID: 30074076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol of the PLeural Effusion And Symptom Evaluation (PLEASE) study on the pathophysiology of breathlessness in patients with symptomatic pleural effusions.
    Thomas R; Azzopardi M; Muruganandan S; Read C; Murray K; Eastwood P; Jenkins S; Singh B; Lee YC
    BMJ Open; 2016 Aug; 6(8):e013213. PubMed ID: 27489159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective randomized trial of intrapleural bleomycin versus interferon alfa-2b via ultrasound-guided small-bore chest tube in the palliative treatment of malignant pleural effusions.
    Sartori S; Tassinari D; Ceccotti P; Tombesi P; Nielsen I; Trevisani L; Abbasciano V
    J Clin Oncol; 2004 Apr; 22(7):1228-33. PubMed ID: 15051770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.